Global Coronary Stents Market (Bare Metal, Drug-Eluting, Bioresorable): Analysis By Segment, By Region, By Country (2016-2021) – (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK, Germany, India, Japan, China, Brazil, UAE; Stents – Pipeline Analysis)

December 2016 | 158 pages | ID: G702DCB7CBDEN
Azoth Analytics

Abstracts

Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research,the report aims to present the analysis of global coronary stent market on the basis of Segments (Bare Metal stents or BMS, Drug-Eluting Stents or DES and Bioresorbable Stents), By Region (North America, Europe, APAC and ROW)and By Country (USA, Canada,UK, Germany, India, Japan, China, Brazil, UAE).

Rising development of bioresorbable stents combined with the growing awareness towards cardiovascular risks in developing countries has resulted in the growth of coronary stents market. Cardiovascular diseases are witnessing growth on account of the rise in the lifestyle related diseases including obesity,diabetes, hypertension etc.

Among the types of coronary stents, market is expected to be driven by bioresorbable stents, mainly in the polylactic acid material. However, drug eluting stents will continue to generate major revenue while bare metal stents will further continue to decline.

While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population.

Global Coronary Stents Market is forecasted to grow at a CAGR of 3.05% during 2016 – 2021F, on account of rising incidences of cardiovascular diseases globally leading to growing number of stent procedures.

The North American region remains the major market followed by Europe in the actual period, while APAC and ROW will witness strong growth in the forecast period.

According to Azoth Analytics research report, Global Coronary Stents (Bare Metal,Drug-Eluting, Bioresorable) Market: Analysis By Segment, By Region, By Country(2016-2021) – (By Segment - Bare Metal stents (BMS), Drug-Eluting Stents (DES), Bioresorbable Stents; By Region - North America, Europe, APAC, ROW; By Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE), Global Coronary Stents market is projected to exhibit a CAGR of over ~3.05%during 2016 - 2021. On the basis of market segment, Global Coronary Stents Markethas been segmented as Bare Metal stents (BMS), Drug-ElutingStents (DES) and Bioresorbable Stents; analysed by Regions-North America, Europe, APAC, ROW and by Country - USA, Canada, UK,Germany, India, Japan, China, Brazil, UAE.

Scope of the Report

The report provides Segmentation by Stent Type

• Bare Metal stents
• Drug-Eluting Stents
• Bioresorbable Stents

The report provides coverage by Region

• North America
• Europe
• Asia Pacific
• ROW

The report provides coverage by Country

• USA
• Canada
• UK
• Germany
• India
• Japan
• China
• Brazil
• UAE

Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.

Contents

1. Research Methodology

2. EXECUTIVE SUMMARY

3. STRATEGIC RECOMMENDATIONS

3.1. Bioresorbable Stents as the Future Market
3.2. Focus on Lowering of ASP in Coronary Stents
3.3. Opportunities in APAC Region

4. GLOBAL CORONARY STENTS MARKET: AN ANALYSIS

4.1. Product Overview
4.2. Global Coronary Stents Market
  4.2.1. By Value (Historic 2011-15)
  4.2.2. By Value ( Forecast 2016E-2021F)
4.3. Global Coronary Stent Market, By Segments
  4.3.1. In Percentage (2015)
  4.3.2. In Percentage (2021F)
4.4. Global Bare Metal Stents, By Value
  4.4.1. By Value (Historic 2011-15)
  4.4.2. By Value (Forecast 2016E-2021F)
4.5. Global Drug Eluting Stents, By Value
  4.5.1. By Value (Historic 2011-15)
  4.5.2. By Value ( Forecast 2016E-2021F)
4.6. Global Bioresorbable Stents Market, By Segments
  4.6.1. By Value (Historic 2011-15)
  4.6.2. By Value ( Forecast 2016E-2021F)
4.7. Global Coronary Stent Market, By Region
  4.7.1. In Percentage (2015)
  4.7.2. In Percentage (2021F)
4.8. Coronary Stents: Pipeline Analysis

5. NORTH AMERICA CORONARY STENT MARKET: AN ANALYSIS

5.1 North America Coronary Stent Market, By Value
  5.1.1. By Value (Historic 2011-15)
  5.1.2. By Value (Forecast 2016E-2021F)
5.2 North America Bare Metal Stent Market , By Value
  5.2.1. By Value (Historic 2011-15)
  5.2.2. By Value ( Forecast 2016E-2021F)
5.3 North America Drug Eluting Stent Market , By Value
  5.3.1. By Value (Historic 2011-15)
  5.3.2. By Value ( Forecast 2016E-2021F)
5.4 North America Bioresorbable Stent Market , By Value
  5.4.1. By Value ( 2011-2021F)
5.5 North America Coronary Stent Market, By Country , By Percentage
  5.5.1. In Percentage (2015)
  5.5.2. In Percentage (2021F)
5.6 North America Coronary Stent Market, By Country (USA, Canada) (2011-2021F)
  5.6.1. USA Coronary Stents Market, By Value
    5.6.1.1 By Value ( 2011-2021F)
  5.6.2 Canada Coronary Stents Market, By Value
    5.6.2.1. By Value ( 2011-2021F)

6. EUROPE CORONARY STENT MARKET: AN ANALYSIS

6.1 Europe Coronary Stent Market , By Value
  6.1.1. By Value (Historic 2011-15)
  6.1.2. By Value ( Forecast 2016E-2021F)
6.2 Europe Bare Metal Stent Market , By Value
  6.2.1. By Value (Historic 2011-15)
  6.2.2. By Value ( Forecast 2016E-2021F)
6.3 Europe Drug Eluting Stent Market , By Value
  6.3.1. By Value (Historic 2011-15)
  6.3.2. By Value ( Forecast 2016E-2021F)
6.4 Europe Bioresorbable Stent Market , By Value
  6.4.1 By Value (Historic 2012-15)
  6.4.2. By Value ( Forecast 2016E-2021F)
6.5 Europe Coronary Stent Market, By Country , By Percentage
  6.5.1 In Percentage (2015)
  6.5.2 In Percentage (2021F)
6.6 Europe Coronary Stent Market, By Country (UK, Germany(2011-2021F)
  6.6.1 UK Coronary Stents Market, By Value
    6.6.1.1 By Value ( 2011-2021F)
  6.6.2. Germany Coronary Stents Market, By Value
    6.6.2.1. By Value ( 2011-2021F)

7. APAC CORONARY STENT MARKET: AN ANALYSIS

7.1. APAC Coronary Stent Market , By Value
  7.1.1. By Value (Historic 2011-15)
  7.1.2. By Value ( Forecast 2016E-2021F)
7.2. APAC Bare Metal Stent Market , By Value
  7.2.1. By Value (Historic 2011-15)
  7.2.2. By Value ( Forecast 2016E-2021F)
7.3. APAC Drug Eluting Stent Market , By Value
  7.3.1. By Value (Historic 2011-15)
  7.3.2. By Value ( Forecast 2016E-2021F)
7.4. APAC Bioresorbable Stent Market , By Value
  7.4.1. By Value ( Forecast 2011-2021F)
7.5. APAC Coronary Stent Market, By Country , By Percentage
  7.5.1. In Percentage (2015)
  7.5.2. In Percentage (2021F)
7.6. APAC Coronary Stent Market, By Country (China, Japan , India) (2011-2021F)
  7.6.1 China Coronary Stents Market, By Value
    7.6.1.1 By Value ( 2011-2021F)
  7.6.2 Japan Coronary Stents Market, By Value
    7.6.2.1 By Value ( 2011-2021F)
  7.6.3 India Coronary Stents Market, By Value
    7.6.3.1 By Value ( 2011-2021F)

8. ROW CORONARY STENT MARKET: AN ANALYSIS

8.1. ROW Coronary Stent Market , By Value
  8.1.1. By Value (Historic 2011-15)
  8.1.2. By Value ( Forecast 2016E-2021F)
8.2. ROW Bare Metal Stent Market , By Value
  8.2.1. By Value (Historic 2011-15)
  8.2.2. By Value ( Forecast 2016E-2021F)
8.3. ROW Drug Eluting Stent Market , By Value
  8.3.1. By Value (Historic 2011-15)
  8.3.2. By Value ( Forecast 2016E-2021F)
8.4. ROW Bioresorbable Stent Market , By Value
  8.4.1. By Value ( Forecast 2012-2021F)
8.5. ROW Coronary Stent Market, By Country , By Percentage
  8.5.1. In Percentage (2015)
  8.5.2. In Percentage (2021F)
8.6. ROW Coronary Stent Market, By Country (Brazil, UAE) (2011-2021F)
  8.6.1 Brazil Coronary Stents Market, By Value
    8.6.1.1. By Value ( 2011-2021F)
  8.6.2 UAE Coronary Stents Market, By Value
    8.6.2.1. By Value ( 2011-2021F)

9. MARKET DYNAMICS

9.1. Trends
9.2. Drivers
9.3. Challenges

10. PRICING STRUCTURE

11. POLICY AND REGULATORY LAND SCAPE

12. M&A AND LICENSING ROUTE TO CORONARY STENT MARKET

13. SWOT ANALYSIS

14. PORTER’S FIVE FORCES MODEL

15. PRODUCT BENCHMARKING

16. COMPANY PROFILING

16.1 Terumo Corporation
16.2 Boston Scientific
16.3 Stentys SA
16.4 MicroPort Scientific Corporation
16.5. Biotronik
16.6 Elixir Medical Corporation
16.7 Biosensors Inc.
16.8 Medtronic
16.9 Abbott Laboratories
16.10 Kyoto Medical Planning

List Of Figures

LIST OF FIGURES

Figure 1: Global Coronary Stent Market Size, By Value, 2011-2021F (USD Billion)
Figure 2: Number of Annual Deaths Due to Cardiovascular Diseases
Figure 3: Life and Non Life Insurance Penetration in Select Countries 2015 in Percentage
Figure 4: Global Coronary Stent Market Segment Share 2015 In Percentage
Figure 5: Global Coronary Stent Market Segment Share 2021 In Percentage
Figure 6: Global Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 7: Global Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Billion
Figure 8: Global Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 9: Global Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 10: Global Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 11: Global Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 12: Global Coronary Stent Market Region Share 2015 In Percentage
Figure 13: Global Coronary Stent Market Region Share 2021 In Percentage
Figure 14: North America Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 15: North America Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 16: Payment for Cardiology Services in USA
Figure 17: North America Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 18: North America Bare Metal Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 19: North America Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 20: North America Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 21: North America Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 22: North America Coronary Stent Market, By Country – 2015(%)
Figure 23: North America Coronary Stent Market, By Country – 2021F(%)
Figure 24: USA Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 25: USA Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 26: Percentage of Population Suffering From Cardiovascular Disease in USA (2009-2012)
Figure 27: Direct and Indirect Costs Associated With Major Heart Diseases in USA (USD Billion) (2009-2012)
Figure 28: Canada Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 29: Canada Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 30: Europe Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 31: Europe Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 32: Cost of CVD in 2014 in some European Countries
Figure 33: Europe Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 34: Europe Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million
Figure 35: Europe Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 36: Europe Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 37: Europe Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 38: Europe Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 39: Europe Coronary Stent Market, By Country – 2015(%)
Figure 40: Europe Coronary Stent Market, By Country – 2021F(%)
Figure 41: UK Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 42: UK Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 43: Germany Coronary Stents Market, By Value , Historic(2011-2015) in USD Million
Figure 44: Germany Coronary Stents Market By Value , Forecast(2016E-2021F) in USD Million
Figure 45: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 46: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 47: APAC Coronary Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 48: APAC Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 49: APAC Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 50: APAC Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million
Figure 51: APAC Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 52: APAC Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 53: APAC Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 54: APAC Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 55: APAC Coronary Stent Market, By Country – 2015(%)
Figure 56: APAC Coronary Stent Market, By Country – 2021F(%)
Figure 57: China Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 58: China Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 59: Japan Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 60: Japan Coronary Market By Value , Forecast(2016E-2021F) in USD Million
Figure 61: India Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 62: India Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 63: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 64: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 65: ROW Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 66: ROW Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 67: ROW Bare Metal Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 68: ROW Bare Metal Stent Market, By Value , Forecast(2016E-2021F) in USD Million
Figure 69: ROW Drug Eluting Stent Market, By Value , Historic(2011-2015) in USD Billion
Figure 70: ROW Drug Eluting Stent Market By Value , Forecast(2016E-2021F) in USD Billion
Figure 71: ROW Bioresorbable Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 72: ROW Bioresorbable Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 73: ROW Coronary Stent Market, By Country – 2015(%)
Figure 74: ROW Coronary Stent Market, By Country – 2021F(%)
Figure 75: Brazil Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 76: Brazil Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 77: UAE Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 78: UAE Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 79: Causes of Death in UAE
Figure 80: Others Coronary Stent Market, By Value , Historic(2011-2015) in USD Million
Figure 81: Others Coronary Stent Market By Value , Forecast(2016E-2021F) in USD Million
Figure 82: Average Price of Bare-metal stents
Figure 83: Average Price of Drug Eluting stents
Figure 84: Cardiac And Vascular Business, By Segment-2015
Figure 85: Cardiac And Vascular Business, By Geography - 2015
Figure 86: Revenue, By Segment-2015 (in Percentage)
Figure 87: Revenue, By Geography - 2015
Figure 88: Revenue, By Segment-2015 (in Percentage)
Figure 89: Revenue, By Geography - 2015
Figure 90: Revenue, By Segment-2015 (in Percentage)
Figure 91: Cardiac and Vascular Group Revenue, By Geography - 2015
Figure 92: Revenue, By Segment-2015 (in Percentage)
Figure 93: Overall Revenue, By Geography – 2015
List of Tables
Table 1: Number of Physicians in Cardiology in Canada in 2016
Table 2: Average Price of Bare-metal stents
Table 3: Average Price of Drug Eluting stents
Table 4: Cardio and Vascular Business Revenue By Segment (in USD Billion)